Ku G, Brahn E, Kronenberg M
Department of Microbiology, UCLA College of Letters and Science.
Cell Immunol. 1990 Oct 15;130(2):472-89. doi: 10.1016/0008-8749(90)90288-3.
Rat/mouse T-T hybridomas have been developed from an arthritogenic and a nonarthritogenic T cell line. These hybridomas express alpha beta TCR and are CD4+, CD8-, and MRC OX-22-. They have type II collagen reactivity as assessed by an IL-2 release assay. Southern blot analysis of DNA extracted from these hybridomas demonstrates that each T cell line contains at least three different collagen-reactive clones. The data suggest that the spectrum of TCR beta gene rearrangements is limited, as one hybridoma from the nonpathogenic line shares an identically sized productive TCR beta gene rearrangement with two hybridomas from the pathogenic line. Both cell lines as well as one hybridoma from the pathogenic line are autoreactive to rat type II collagen. The anti-collagen responses of all the hybridomas are restricted to the rat class II MHC RT1.B gene loci. The hybridomas, like their parental cell lines, do not respond preferentially to either native or denatured type II collagen. These hybridomas recognize a specific type II collagen epitope and not repetitive collagen-like sequence motifs. They require antigen processing to respond to both native and denatured type II collagen.
大鼠/小鼠T-T杂交瘤是由致关节炎和非致关节炎的T细胞系构建而成。这些杂交瘤表达αβTCR,为CD4+、CD8-且MRC OX-22-。通过白细胞介素-2释放试验评估,它们具有II型胶原反应性。对从这些杂交瘤中提取的DNA进行Southern印迹分析表明,每个T细胞系至少包含三个不同的胶原反应性克隆。数据表明,TCRβ基因重排的谱是有限的,因为来自非致病系的一个杂交瘤与来自致病系的两个杂交瘤共享大小相同的有功能的TCRβ基因重排。两个细胞系以及来自致病系的一个杂交瘤对大鼠II型胶原均具有自身反应性。所有杂交瘤的抗胶原反应均局限于大鼠II类MHC RT1.B基因座。这些杂交瘤与其亲本细胞系一样,对天然或变性II型胶原均无优先反应。这些杂交瘤识别特定的II型胶原表位,而非重复的胶原样序列基序。它们需要抗原加工才能对天然和变性II型胶原作出反应。